In partnership with

AIHealthTech Insider: Issue # 107

June 29, 2026

This week, the first AI that can actually treat you — not just answer your questions — got FDA clearance and is already live inside Cleveland Clinic. A routine heart test just learned to find disease your cardiologist would miss. And the weight-loss drug that changed medicine may soon lose the one thing that kept millions from trying it. The needle.

Summaries are for education, not medical advice. Always verify locally before clinical use.

🔬 The Big Story

The First FDA-Cleared AI That Actually Delivers Care Just Launched — and It's Already Inside Cleveland Clinic

Most healthcare AI answers questions. UpDoc just got cleared to act on them.

UpDoc announced FDA clearance for the first Software as a Medical Device that uses patient-facing large language models — a clinical AI platform already deployed at Cleveland Clinic, UCSF Health, and Allegheny Health Network, backed by $18 million from investors including Mayo Clinic and Eli Lilly.

Here's what that actually means in practice: a diabetes patient's blood glucose drifts out of range. UpDoc detects it, adjusts the insulin dose within physician-approved limits, orders the follow-up test, and documents everything in the patient's record — without a single appointment.

"This FDA clearance marks the beginning of a new era where clinicians can deploy AI agents to complete tasks autonomously on their behalf much like engineers deploy coding agents today," said UpDoc CEO Sharif Vakili, MD.

This isn't a chatbot in a lab coat. It's the first AI that's been cleared to do what doctors do between visits and it just went live.

New here? This is AIHealthTech Insider — AI healthcare signals every week, plain English, no jargon. Subscribe free below.

Sponsored

The best prompt engineers aren't typing. They're talking.

Power users figured this out early: speaking a prompt gives you 10x more context in half the time. You include the edge cases, the examples, the tone you want — because talking is fast enough that you don't skip them.

Wispr Flow captures everything you say and turns it into clean, structured text for any AI tool. Speak messy. Get polished input. Paste into ChatGPT, Claude, Cursor, or wherever you work.

89% of messages sent with zero edits. 4x faster than typing. Works system-wide on Mac, Windows, and iPhone.

⚡ Quick Hits

Image: AI-generated, AIHealthTech Insider

🔸A Voice AI Just Raised $120M to Answer Every Patient Call — In Any Language

Assort Health hit unicorn status at $1.2 billion after raising $120 million in Series C funding to scale its voice AI platform built on 190 million patient interactions that handles the entire patient journey from scheduling and triage to lab requests, medication refills, insurance eligibility, and payments, in any language. The phone call nobody answered just became the AI that never stops.

🔸Primary Care Doctors Would Need to Work 27 Hours a Day to Keep Up. AI Is the Only Math That Works.

A new Insight Partners analysis found primary care physicians would need to work nearly 27 hours per day to complete all recommended care and administrative tasks with nearly half already reporting burnout and the training pipeline structurally capped, leaving AI as the only viable lever to close the gap. The workforce crisis isn't coming. It's already here.

🔸An ECG Just Got FDA Clearance to Find Heart Disease Your Cardiologist Would Miss

EchoNext developed at NewYork-Presbyterian and Columbia just received the world's first FDA clearance for AI detection of hidden structural heart disease through a routine ECG. Trained on 700,000 ECG-echocardiogram pairs, it identified structural heart problems with 77% accuracy versus 64% for cardiologists reading the same data. You've had ECGs before. They were never able to find this. Now they can.

Sponsored

Don't be the one behind at standup

Your team is already talking about the launch you missed. TLDR is the 5-minute daily brief that keeps you ahead, curated by ex-Google and Anthropic engineers. Free, and read by 7M+ subscribers.

Know someone in healthcare, medicine, or AI? Forward this to them. They can subscribe free here

🌍 Beyond AI

Ozempic Without the Needle Just Got One Step Closer

Ozempic works. The problem is everything around it — the needle, the refrigeration, the cost, the shortage. A new study published in Nature Medicine just moved the next version one significant step closer.

Image: AI-generated, AIHealthTech Insider

A randomized, double-blind Phase II trial of 230 adults found that aleniglipron — a new oral GLP-1 drug taken once daily as a small-molecule pill — delivered up to 12% body weight reduction in 36 weeks, with mild side effects that decreased over time and no liver injury events reported across any dose group.

Here's what makes this different from every GLP-1 drug on the market today: it's a pill. No injection. No refrigeration. No needle. "Because it's a small molecule, it can potentially be combined with other medications," said study co-author Dr. Robert Kushner of Northwestern University — meaning one pill could eventually treat obesity alongside blood pressure, diabetes, or cholesterol simultaneously.

The drug enters Phase III next. That's the last gate before a pharmacy shelf.

Sponsored

From idea to shipped tool in 11 minutes.

Type the problem in Slack. Viktor writes the code, deploys to your subdomain, posts the URL, and starts using it on your next request. No specs, no Jira, no kickoff. Founders are running entire companies this way.

Quick question before you go 👇

Image: AI-generated, AIHealthTech Insider

Stay ahead: AI Healthcare News!

This is just a glimpse of the AI healthcare revolution. Subscribe for exclusive updates on medicine’s future!

Reply

Avatar

or to participate

Keep Reading